Also categorized in PubMed:
Treatment of chronic graft versus host disease with bortezomib.
x hide permanently

Invariant natural killer T infiltration in neuroblastoma with favorable outcome.

ncbi.nlm.nih.gov

Invariant natural killer T infiltration in neuroblastoma with favorable outcome.

Pediatr Surg Int. 2017 Oct 10;:

Authors: Hishiki T, Mise N, Harada K, Ihara F, Takami M, Saito T, Terui K, Nakata M, Komatsu S, Yoshida H, Motohashi S

Abstract BACKGROUND: Tumor immunity has been suggested to play a key role in clinical and biological behavior of neuroblastomas.